Member Info for oogleflugal

usually have notice of final results by now followed by the results end of july. perhaps they just can’t be ****d anymore. no contract no nothing.

Looks like japan dumped all their junk stock on Uk japanese investment trusts. Nikkei now 25% up while the trusts languish around their miserable lows. Cunning plan investing in unlisted companies that nobody wants to buy.

It was the lack of patent need that concerned me more than anything else. Without it how were they going to achieve commerciality in the face of fierce competition particularly in America. This should give drug partners a lot more confidence to fully commit.

Patent news update in the states is the next best news to commerciality. The amount of money being thrown at this field of research is staggering so its important that N4p intellectual property is fortified.

But is it a buy yet Ed? Or just flogging a dead horse

Funny how directors like to award themselves bucket loads of shares when a company is performing poorly. Like little piggies at the trough. Not totally against the idea of options as an incentive but this looks like sheer greed. Why do shareholders shoulder all the risk for directors to take no risk in share purchase schemes. Another one added to my black list I’m afraid

This is where Mr Rawlinson earns his keep. Quick access to money!

You got it!

Whatever the reason for the delay fro other lenders, the ability to act quickly and decisively is proof enough of where this is heading. The market hates the unexpected but this was an astute move in the circumstances and the loan noters will probably be only too willing to convert to shares in due course. Short term fix for long term gain.

Another fund raise to follow. Best of luck with that. Avoid

A company that constantly deals from the bottom of the pack cannot be trusted I’m afraid

Great time to be able to use up some of the 600 million tax loss carry over!

As promised more regular updates to market. Records, records and more records!

What an exceptionally untalented bunch they are at BG. Don’t know how they do it. Japanese stocks go in one direction, up and BG trusts actually manage to head in the opposite direction. Staggering

Looks like breaking in to a new upward trend

I’ve bought and sold kmk 3 times and made a small amounts each time. Has been an excellent trading stock. I stopped because It was obvious lending was tightening up and as your excellent report points to the problem of scaling up to fill the market size they would like to attain. It’s seems they are in a continual spiral the wrong way. Their first big hype was the radiation detector which doesn’t appear to have attracted the game changing orders they or Thompson forecast. It’s a fast moving sector with constant and regular updates and revisions are needed to keep pace with the competition. Avg seem to have potential industry standard equipment that will be in service for years. Kmk is sort of tempting at 5p but 13 years without profit and almost annual raises are a bit of a clue about their predicament. Avg latest deal is to buy a 80 percent of a company for less than their initial 10 percent stake. Careful what you wish for!

Further extension. Some progress at last. Entering ‘due diligence process’ is a lot more encouraging. Interesting to see how the market views this statement if at all. Must be worth a good punt for anyone not already invested. I would not add more because clearly there must be a bit of a gulf as to what is acceptable to both sides. I imagine SMV want well over a pound and Pexa need to know why and are prepared to thoroughly investigate. gl all

Are you sure about their products. I see kmk as a bit of a gadget company. Don’t think that would fit here. Must have had about ten raises so far. Dilution is spectacular. Avg medical arm is producing an almost portable scanner. This really could be massive. Interesting that they are focusing on the States first. Market seems to have woken up to that thisafternoon

Am waiting to see what stockopedia make of it. It is a bit jam tomorrow on the scan and x-ray combination but what a bumper crop that could be. As to the rest of the business as Chris Mills says more than backs up the current sp. So the medical side is a free ride!

Very solid inline update. Possible completion of the rest of Adaptix which has phenomenal potential. Great under the radar stock in the Harwood capital folio. Looks very good value still . Could rerate again this year